AAMU
APLS

Amundi Asset Management US’s Apellis Pharmaceuticals APLS Stock Holding History

Amundi Asset Management US’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$313K Hold
7,300
– – ﹤0.01% 1407
2020
Q4 		$418K Hold
7,300
– – ﹤0.01% 1318
2020
Q3 		$220K Buy
7,300
+3,700
+103% +$111K ﹤0.01% 1376
2020
Q2 		$118K Buy
3,600
+1,100
+44% +$35.3K ﹤0.01% 1430
2020
Q1 		$67K Buy
2,500
+1,000
+67% +$35.5K ﹤0.01% 1455
2019
Q4 		$46K Hold
1,500
– – ﹤0.01% 1573
2019
Q3 		$36K Buy
+1,500
New +$41.3K ﹤0.01% 1577

Other funds holding APLS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return